Free Trial

AXIS Capital (AXS) Short Interest Ratio & Short Volume

$72.21
+1.01 (+1.42%)
(As of 07/16/2024 ET)

AXIS Capital Short Interest Data

Current Short Interest
1,060,000 shares
Previous Short Interest
1,170,000 shares
Change Vs. Previous Month
-9.40%
Dollar Volume Sold Short
$74.89 million
Short Interest Ratio
1.8 Days to Cover
Last Record Date
June 30, 2024
Outstanding Shares
84,660,000 shares
Float Size
77,260,000 shares
Short Percent of Float
1.37%
Today's Trading Volume
352,021 shares
Average Trading Volume
603,601 shares
Today's Volume Vs. Average
58%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling AXIS Capital ?

Sign up to receive the latest short interest report for AXIS Capital and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

AXS Short Interest Over Time

AXS Days to Cover Over Time

AXS Percentage of Float Shorted Over Time

AXIS Capital Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/20241,060,000 shares $74.89 million -9.4%1.4%1.8 $70.65
6/15/20241,170,000 shares $79.92 million -0.9%1.5%2 $68.31
5/31/20241,180,000 shares $87.15 million -18.1%1.5%2 $73.86
5/15/20241,440,000 shares $100.53 million +48.2%1.9%2.4 $69.81
4/30/2024971,500 shares $59.58 million +2.4%1.2%1.6 $61.33
4/15/2024948,700 shares $58.04 million +0.5%1.2%1.4 $61.18
3/31/2024944,400 shares $61.40 million -4.3%1.2%1.5 $65.02
3/15/2024986,900 shares $62.30 million -3.3%1.3%1.6 $63.13
2/29/20241,020,000 shares $63.83 million -20.9%1.3%1.7 $62.58
2/15/20241,290,000 shares $80.07 million +10.3%1.7%2.1 $62.07
1/31/20241,170,000 shares $69.76 million +12.5%1.5%1.9 $59.62
1/15/20241,040,000 shares $57.65 million -14.1%1.3%1.8 $55.43
12/31/20231,210,000 shares $67.00 million +9.0%1.6%2.3 $55.37
12/15/20231,110,000 shares $60.23 million +4.7%1.4%2.2 $54.26
11/30/20231,060,000 shares $59.72 million +2.9%1.4%2.1 $56.34
11/15/20231,030,000 shares $55.99 million +17.5%1.3%2.2 $54.36
10/31/2023877,000 shares $50.08 million +1.9%1.1%1.9 $57.10
10/15/2023860,300 shares $49.72 million -26.5%1.1%2 $57.79
9/30/20231,170,000 shares $65.95 million +46.9%1.5%2.7 $56.37
9/15/2023796,600 shares $45.73 million -1.1%1.0%1.8 $57.41
8/31/2023805,500 shares $44.21 million +9.8%1.0%1.9 $54.88
8/15/2023733,600 shares $40.46 million +27.2%1.0%1.7 $55.15
7/31/2023576,800 shares $31.78 million -15.1%0.8%1.3 $55.10
7/15/2023679,700 shares $35.78 million -0.3%0.9%1.5 $52.64
6/30/2023681,700 shares $36.70 million +8.0%0.9%1.5 $53.83
6/15/2023631,500 shares $34.18 million -36.9%0.8%1.3 $54.13
5/31/20231,000,000 shares $51.90 million +4.7%1.3%1.8 $51.90
5/15/2023955,400 shares $52.58 million +21.5%1.2%1.6 $55.03
4/30/2023786,300 shares $44.46 million +40.1%1.0%1.3 $56.54
4/15/2023561,200 shares $31.01 million -11.3%0.7%0.9 $55.26
3/31/2023632,400 shares $34.48 million -49.0%0.8%1.1 $54.52
3/15/20231,240,000 shares $65.55 million +19.2%1.6%2.2 $52.86
2/28/20231,040,000 shares $63.15 million +10.3%1.4%2.1 $60.72
2/15/2023942,500 shares $58.98 million -23.4%1.2%1.9 $62.58
1/31/20231,230,000 shares $76.96 million +21.8%1.6%2.6 $62.57
1/15/20231,010,000 shares $57.47 million -2.9%1.3%2 $56.90
12/30/20221,040,000 shares $56.34 million +13.3%1.3%2 $54.17
12/15/2022917,900 shares $51.26 million -4.7%1.2%1.7 $55.85
11/30/2022963,600 shares $55.46 million +47.0%1.2%1.8 $57.56
11/15/2022655,500 shares $35.98 million -14.0%0.8%1.2 $54.89
Human testing is the last step before this company goes big (Ad)

Biotech innovations have the potential to change the world. And help you build wealth in the process.

You can learn more about it here.
10/31/2022762,300 shares $41.67 million -37.0%1.0%1.5 $54.67
10/15/20221,210,000 shares $60.49 million -13.6%1.6%2.6 $49.99
9/30/20221,400,000 shares $68.81 million +29.6%1.8%3.3 $49.15
9/15/20221,080,000 shares $58.33 million +3.9%1.4%2.7 $54.01
8/31/20221,040,000 shares $55.28 million +12.6%1.4%2.6 $53.15
8/15/2022923,700 shares $50.18 million +11.9%1.2%2.3 $54.33
7/31/2022825,800 shares $41.69 million +22.7%1.1%1.7 $50.49
7/15/2022672,900 shares $34.90 million -35.3%0.9%1.2 $51.87
6/30/20221,040,000 shares $59.37 million +20.6%1.3%1.9 $57.09
6/15/2022862,100 shares $47.83 million +16.5%1.1%1.5 $55.48
5/31/2022739,800 shares $43.33 million +6.7%1.0%1.2 $58.57
5/15/2022693,200 shares $38.31 million -42.7%0.9%1 $55.27
4/30/20221,210,000 shares $69.37 million -19.9%1.6%1.9 $57.33
4/15/20221,510,000 shares $85.42 million -2.0%2.0%2.6 $56.57
3/31/20221,540,000 shares $93.12 million +33.9%2.0%2.7 $60.47
3/15/20221,150,000 shares $61.19 million +25.9%1.5%2.2 $53.21
2/28/2022913,700 shares $49.91 million +3.0%1.2%1.9 $54.62
2/15/2022887,000 shares $50.20 million +1.0%1.2%2 $56.60
1/31/2022878,300 shares $50.05 million +7.5%1.1%2.2 $56.98
1/15/2022817,100 shares $46.57 million -7.0%1.1%2.3 $57.00
12/31/2021878,200 shares $47.84 million +24.2%1.1%2.4 $54.47
12/15/2021707,000 shares $36.76 million +8.8%0.9%1.8 $51.99
11/30/2021650,000 shares $32.29 million -15.4%0.8%1.5 $49.68
11/15/2021768,400 shares $40.96 million -27.5%1.0%1.7 $53.31
10/29/20211,060,000 shares $55.19 million -0.9%1.4%2.3 $52.07
10/15/20211,070,000 shares $55.59 million +38.9%1.4%2.4 $51.95
9/30/2021770,500 shares $35.47 million -20.3%1.0%1.7 $46.04
9/15/2021966,400 shares $45.36 million +27.6%1.3%2.3 $46.94
8/31/2021757,300 shares $38.75 million -16.8%1.0%1.9 $51.17
8/13/2021910,000 shares $48.46 million +4.8%1.2%2.4 $53.25
7/30/2021868,000 shares $44.16 million +2.5%1.1%2.2 $50.87
7/15/2021847,100 shares $42.40 million +6.2%1.1%2.2 $50.05
6/30/2021797,700 shares $39.10 million +5.8%1.0%2.1 $49.01
6/15/2021754,100 shares $39.12 million +15.4%1.0%2.1 $51.88
5/28/2021653,700 shares $35.06 million -22.3%0.9%1.7 $53.64
5/14/2021840,800 shares $47.30 million -2.9%1.1%2.1 $56.26
4/30/2021866,000 shares $48.31 million +16.5%1.1%2.1 $55.78
4/15/2021743,400 shares $39.16 million -11.7%1.0%1.7 $52.68
3/31/2021841,500 shares $42.77 million -25.5%1.1%1.9 $50.83
3/15/20211,130,000 shares $58.43 million -5.0%1.5%2.6 $51.71
2/26/20211,190,000 shares $59.60 million -15.6%1.6%2.9 $50.08
2/12/20211,410,000 shares $72.50 million +29.4%1.9%3.5 $51.42
1/29/20211,090,000 shares $49.05 million +0.9%1.5%2.6 $45.00
1/15/20211,080,000 shares $55.79 million +0.9%1.4%2.6 $51.66
12/31/20201,070,000 shares $53.52 million -1.8%1.4%2.5 $50.02
12/15/20201,090,000 shares $55.86 million -19.9%1.5%2.4 $51.25
11/30/20201,360,000 shares $70.50 million -4.9%1.8%2.5 $51.84
11/15/20201,430,000 shares $69.44 million -19.7%1.9%2.3 $48.56
10/30/20201,780,000 shares $79.25 million -8.7%2.4%2.4 $44.52
10/15/20201,950,000 shares $88.59 million -20.4%2.7%2.5 $45.43
Human testing is the last step before this company goes big (Ad)

Biotech innovations have the potential to change the world. And help you build wealth in the process.

You can learn more about it here.
9/30/20202,450,000 shares $107.90 million -11.6%3.4%2.9 $44.04
9/15/20202,770,000 shares $126.17 million +9.5%3.8%2.9 $45.55
8/31/20202,530,000 shares $120.83 million +62.2%3.5%2.5 $47.76
8/14/20201,560,000 shares $71.76 million +12.2%2.1%1.6 $46.00
7/31/20201,390,000 shares $55.77 million -17.8%1.8%1.5 $40.12
7/15/20201,690,000 shares $66.64 million -24.6%2.1%1.8 $39.43
6/30/20202,240,000 shares $90.85 million +73.6%2.8%2.2 $40.56
6/15/20201,290,000 shares $52.81 million +15.2%1.6%1.4 $40.94
5/29/20201,120,000 shares $43.75 million -47.9%1.4%1.2 $39.06
5/15/20202,150,000 shares $73.75 million +82.2%2.6%2.3 $34.30
4/30/20201,180,000 shares $44.63 million +16.8%1.4%1.3 $37.82
4/15/20201,010,000 shares $39.81 million +154.9%1.2%1.3 $39.42
3/31/2020396,200 shares $13.51 million -45.1%0.5%0.6 $34.10
3/13/2020722,100 shares $30.60 million -10.3%0.9%1.4 $42.37
2/28/2020805,000 shares $28.71 million +10.6%1.0%1.6 $35.66
2/14/2020727,700 shares $37.66 million -28.7%0.9%1.4 $51.75
1/31/20201,020,000 shares $63.24 million +25.5%1.3%2 $62.00
1/15/2020813,000 shares $52.97 million -4.0%1.0%1.5 $65.15
12/31/2019847,100 shares $52.58 million +57.6%1.0%1.5 $62.07
7/31/20191,248,700 shares $80.14 million +5.9%1.5%2.5 $64.18

AXS Short Interest - Frequently Asked Questions

What is AXIS Capital's current short interest?

Short interest is the volume of AXIS Capital shares that have been sold short but have not yet been closed out or covered. As of June 30th, investors have sold 1,060,000 shares of AXS short. 1.37% of AXIS Capital's shares are currently sold short. Learn More on AXIS Capital's current short interest.

What is a good short interest ratio for AXIS Capital?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AXS shares currently have a short interest ratio of 2.0. Learn More on AXIS Capital's short interest ratio.

Which institutional investors are shorting AXIS Capital?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AXIS Capital: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for AXIS Capital?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.37% of AXIS Capital's floating shares are currently sold short.

Is AXIS Capital's short interest increasing or decreasing?

AXIS Capital saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 1,060,000 shares, a drop of 9.4% from the previous total of 1,170,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is AXIS Capital's float size?

AXIS Capital currently has issued a total of 84,660,000 shares. Some of AXIS Capital's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. AXIS Capital currently has a public float of 77,260,000 shares.

How does AXIS Capital's short interest compare to its competitors?

1.37% of AXIS Capital's shares are currently sold short. Here is how the short interest of companies compare to AXIS Capital: Markel Group Inc. (1.02%), W. R. Berkley Co. (2.80%), Erie Indemnity (1.68%), Cincinnati Financial Co. (1.48%), Fidelity National Financial, Inc. (1.45%), CNA Financial Co. (0.41%), Old Republic International Co. (1.53%), RLI Corp. (1.69%), Selective Insurance Group, Inc. (2.06%), First American Financial Co. (1.07%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks.

What does it mean to sell short AXIS Capital stock?

Short selling AXS is an investing strategy that aims to generate trading profit from AXIS Capital as its price is falling. AXS shares are trading up $1.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against AXIS Capital?

A short squeeze for AXIS Capital occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AXS, which in turn drives the price of the stock up even further.

How often is AXIS Capital's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AXS, twice per month. The most recent reporting period available is June, 30 2024.



This page (NYSE:AXS) was last updated on 7/17/2024 by MarketBeat.com Staff

From Our Partners